Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer
Abstract Background High grade serous ovarian cancer (HGSOC) is the most lethal gynecologic malignancy in which patients have still yet to respond meaningfully to clinically available immunotherapies. Hence, novel immune targets are urgently needed. Our past work has identified that mast cells are s...
Enregistré dans:
Auteurs principaux: | , , , , , , , , |
---|---|
Format: | Livre |
Publié: |
BMC,
2024-09-01T00:00:00Z.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Internet
Connect to this object online.3rd Floor Main Library
Cote: |
A1234.567 |
---|---|
Exemplaire 1 | Disponible |